{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:41:34Z","timestamp":1778575294648,"version":"3.51.4"},"reference-count":76,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2014,10,17]],"date-time":"2014-10-17T00:00:00Z","timestamp":1413504000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HEPL"],"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study examined the role of prospective payment systems in the adoption of new medical technologies across different countries. A literature review was conducted to provide background for the study and guide development of a survey instrument. The survey was disseminated to hospital payment systems experts in 15 jurisdictions. Fifty-one surveys were disseminated, with 34 returned. The surveys returned covered 14 of the 15 jurisdictions invited to participate. The majority (71%) of countries update the patient classification system and\/or payment tariffs on an annual basis to try to account for new technologies. Use of short-term separate or supplementary payments for new technologies occurs in 79% of countries to ensure adequate funding and facilitate adoption. A minority (43%) of countries use evidence of therapeutic benefit and\/or costs to determine or update payment tariffs, although it is somewhat more common in establishing short-term payments. The main barrier to using evidence is uncertain or unavailable clinical evidence. Almost three-fourths of respondents believed diagnosis-related group systems incentivize or deter technology adoption, depending on the particular circumstances. Improvements are needed, such as enhanced strategies for evidence generation and linking evidence of value to payments, national and international collaboration and training to improve existing practice, and flexible timelines for short-term payments. Importantly, additional research is needed to understand how different payment policies impact technology uptake as well as quality of care and costs.<\/jats:p>","DOI":"10.1017\/s1744133114000358","type":"journal-article","created":{"date-parts":[[2014,10,17]],"date-time":"2014-10-17T05:09:10Z","timestamp":1413522550000},"page":"133-159","source":"Crossref","is-referenced-by-count":18,"title":["The role of hospital payments in the adoption of new medical technologies: an international survey of current practice"],"prefix":"10.1017","volume":"10","author":[{"given":"Corinna","family":"Sorenson","sequence":"first","affiliation":[]},{"given":"Michael","family":"Drummond","sequence":"additional","affiliation":[]},{"given":"Aleksandra","family":"Torbica","sequence":"additional","affiliation":[]},{"given":"Giuditta","family":"Callea","sequence":"additional","affiliation":[]},{"given":"Ceu","family":"Mateus","sequence":"additional","affiliation":[]}],"member":"56","published-online":{"date-parts":[[2014,10,17]]},"reference":[{"key":"S1744133114000358_ref21","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/europace\/eur089","article-title":"Applying health economics for policy decision making: how much do devices differ from drugs?","volume":"13","author":"Sorenson","year":"2011","journal-title":"Europace"},{"key":"S1744133114000358_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.07.001"},{"key":"S1744133114000358_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(98)00026-5"},{"key":"S1744133114000358_ref11","doi-asserted-by":"publisher","DOI":"10.1179\/175330310X12665793931221"},{"key":"S1744133114000358_ref76","unstructured":"Department of Health (2011), Payment by Results Guidance for 2010\u20132011. London: Department of Health."},{"key":"S1744133114000358_ref6","first-page":"11","article-title":"Is technological change in medicine worth it?","volume":"20","author":"Cutler","year":"2001","journal-title":"Health Affairs"},{"key":"S1744133114000358_ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1740774512450097"},{"key":"S1744133114000358_ref16","doi-asserted-by":"publisher","DOI":"10.1057\/jmm.2009.48"},{"key":"S1744133114000358_ref43","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.5.4.377"},{"key":"S1744133114000358_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2010.10.004"},{"key":"S1744133114000358_ref7","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2010.0666"},{"key":"S1744133114000358_ref35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3047"},{"key":"S1744133114000358_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8510(02)00062-3"},{"key":"S1744133114000358_ref2","volume-title":"Diagnosis-Related Groups in Europe: Moving Towards Transparency, Efficiency, and Quality in Hospitals","author":"Busse","year":"2011"},{"key":"S1744133114000358_ref54","volume-title":"Diagnosis Related Groups (DRGs) and the Medicare Program: Implication for Medical Technology \u2013 A Technical Memorandum","year":"1983"},{"key":"S1744133114000358_ref56","first-page":"5","article-title":"Activity based payment in France","volume":"11","author":"Or","year":"2009","journal-title":"Euro Observer"},{"key":"S1744133114000358_ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s10729-006-9040-1"},{"key":"S1744133114000358_ref113","year":"2003"},{"key":"S1744133114000358_ref41","doi-asserted-by":"publisher","DOI":"10.1002\/hec.2840"},{"key":"S1744133114000358_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2009.03.016"},{"key":"S1744133114000358_ref37","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.5.2.46"},{"key":"S1744133114000358_ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s10729-006-9040-1"},{"key":"S1744133114000358_ref53","volume-title":"The Incentive Effects of Payment by Results","author":"Miraldo","year":"2006"},{"key":"S1744133114000358_ref70","doi-asserted-by":"publisher","DOI":"10.1017\/S174413310700429X"},{"key":"S1744133114000358_ref13","volume-title":"Aligning Incentives in Medicare","year":"2010"},{"key":"S1744133114000358_ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2008.00476_1.x"},{"key":"S1744133114000358_ref73","doi-asserted-by":"publisher","DOI":"10.1057\/jmm.2009.48"},{"key":"S1744133114000358_ref59","first-page":"1","article-title":"The ABC of DRGs","volume":"11","author":"Scheller-Kreinsen","year":"2009","journal-title":"Euro Observer"},{"key":"S1744133114000358_ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-005-0103-4"},{"key":"S1744133114000358_ref42","doi-asserted-by":"publisher","DOI":"10.1179\/175330310X12665793931221"},{"key":"S1744133114000358_ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.0887-378X.2004.00325.x"},{"key":"S1744133114000358_ref74","first-page":"523","article-title":"The health care quadrilemma: an essay on technological change, insurance, quality of care and cost containment","volume":"29","author":"Weisbrod","year":"1991","journal-title":"Journal of Economic Literature"},{"key":"S1744133114000358_ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hpm.4740100104"},{"key":"S1744133114000358_ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-008-0119-0"},{"key":"S1744133114000358_ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s10729-006-9096-y"},{"key":"S1744133114000358_ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2004.12.001"},{"key":"S1744133114000358_ref71","unstructured":"Street A. , Vitikainen K. , Bjorvatn A. and Hvenegaard A. (2007), \u2018Introducing activity-based financing: a review of experience in Australia, Denmark, Norway and Sweden\u2019, CHE Research Paper 20. York: University of York."},{"key":"S1744133114000358_ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s10729-006-9097-x"},{"key":"S1744133114000358_ref65","first-page":"4","article-title":"The DRG reimbursement system in Germany","volume":"7","author":"Schreyogg","year":"2005","journal-title":"Euro Observer"},{"key":"S1744133114000358_ref15","volume-title":"Diagnosis Related Groups (DRGs) and the Medicare Program: Implications for Medical Technology. A Technical Memorandum","year":"1983"},{"key":"S1744133114000358_ref17","first-page":"523","article-title":"The health care quadrilemma: an essay on technological change, insurance, quality of care and cost containment","volume":"29","author":"Weisbrod","year":"1991","journal-title":"Journal of Economic Literature"},{"key":"S1744133114000358_ref22","volume-title":"The right result? Payment by Results 2003\u20132007","year":"2008"},{"key":"S1744133114000358_ref25","first-page":"12","article-title":"Payment by results in England","volume":"13","author":"Boyle","year":"2007","journal-title":"Eurohealth"},{"key":"S1744133114000358_ref26","volume-title":"Diagnosis-Related Groups in Europe: Moving Towards Transparency, Efficiency, and Quality in Hospitals","author":"Busse","year":"2011"},{"key":"S1744133114000358_ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s10729-006-9039-7"},{"key":"S1744133114000358_ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2010.10.004"},{"key":"S1744133114000358_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2009.05.004"},{"key":"S1744133114000358_ref5","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.27.6.1632"},{"key":"S1744133114000358_ref30","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.27.6.1632"},{"key":"S1744133114000358_ref31","doi-asserted-by":"publisher","DOI":"10.1002\/hec.2838"},{"key":"S1744133114000358_ref32","volume-title":"Payment by Results Guidance for 2009\u20132010","year":"2009"},{"key":"S1744133114000358_ref44","doi-asserted-by":"publisher","DOI":"10.1071\/AH010136"},{"key":"S1744133114000358_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(92)90128-X"},{"key":"S1744133114000358_ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta1140","article-title":"When and how to assess fast-changing technologies: a comparative study of medical applications of four generic technologies","volume":"1","author":"Mowatt","year":"1997","journal-title":"Health Technology Assessment"},{"key":"S1744133114000358_ref38","doi-asserted-by":"publisher","DOI":"10.1002\/hec.2848"},{"key":"S1744133114000358_ref39","doi-asserted-by":"publisher","DOI":"10.1097\/QMH.0b013e3181ccbcc3"},{"key":"S1744133114000358_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8510(02)00062-3"},{"key":"S1744133114000358_ref40","doi-asserted-by":"publisher","DOI":"10.1111\/j.0887-378X.2004.00325.x"},{"key":"S1744133114000358_ref45","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8510(01)00216-0"},{"key":"S1744133114000358_ref46","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(98)00026-5"},{"key":"S1744133114000358_ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-004-0267-9"},{"key":"S1744133114000358_ref50","volume-title":"Report to the Congress: Medicare Payment Policy","year":"2003"},{"key":"S1744133114000358_ref51","first-page":"33","volume-title":"Report to the Congress: Medicare Payment Policy","year":"2001"},{"key":"S1744133114000358_ref58","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-5056(03)00044-3"},{"key":"S1744133114000358_ref52","volume-title":"Aligning Incentives in Medicare","year":"2010"},{"key":"S1744133114000358_ref57","doi-asserted-by":"publisher","DOI":"10.1258\/jhsrp.2010.009137"},{"key":"S1744133114000358_ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.07.001"},{"key":"S1744133114000358_ref61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-246X.2009.01344.x"},{"key":"S1744133114000358_ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2009.03.016"},{"key":"S1744133114000358_ref64","doi-asserted-by":"publisher","DOI":"10.1007\/s10729-006-9094-0"},{"key":"S1744133114000358_ref34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S1744133107004276","article-title":"Activity-based payments and reforms of the English hospital payment system","volume":"20","author":"Ellis","year":"2007","journal-title":"Health Economics, Policy and Law"},{"key":"S1744133114000358_ref67","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2251011304"},{"key":"S1744133114000358_ref68","volume-title":"Financing Medical Devices in France and the UK","author":"Sorenson","year":"2008"},{"key":"S1744133114000358_ref69","doi-asserted-by":"publisher","DOI":"10.1002\/hec.2837"},{"key":"S1744133114000358_ref49","doi-asserted-by":"publisher","DOI":"10.1108\/14777260810862425"},{"key":"S1744133114000358_ref66","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1377\/hlthaff.27.6.1566","article-title":"Diffusion of new technology and payment policies: coronary stents","volume":"27","author":"Shin","year":"2008","journal-title":"Health Affairs"}],"container-title":["Health Economics, Policy and Law"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1744133114000358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T22:13:57Z","timestamp":1555798437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1744133114000358\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,17]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S1744133114000358"],"URL":"https:\/\/doi.org\/10.1017\/s1744133114000358","relation":{},"ISSN":["1744-1331","1744-134X"],"issn-type":[{"value":"1744-1331","type":"print"},{"value":"1744-134X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,17]]}}}